Oral infliximab nanomedicines for targeted treatment of inflammatory bowel diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oral infliximab nanomedicines for targeted treatment of inflammatory bowel diseases

Published:2023-04 Issue: Volume:183 Page:106379
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Mohan Lauren J.,Daly Jacqueline S.,Ryan Barbara M.,Ramtoola Zebunnissa^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference39 articles.

1. Effect of thermal and shear stressors on the physical properties, structural integrity and biological activity of the anti-TNF-alpha monoclonal antibody, infliximab;Alsaddique;Curr. Pharm. Biotechnol.,2016

2. The burden of cost in inflammatory bowel disease: a medical economic perspective and the future of value-based care;Beard;Curr. Gastroenterol. Rep.,2020

3. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier;Beloqui;J. Control. Release,2013

4. Cytokine regulation of tight junctions;Capaldo;Biochim. Biophys. Acta (BBA),2009

5. On-treatment decrease of serum interleukin-6 as a predictor of clinical response to biologic therapy in patients with inflammatory bowel diseases;Caviglia;J. Clin. Med.,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomedicine-Mediated Drug Delivery for Potential Treatment of Inflammatory Bowel Disease: A Narrative Review;Nanomedicine;2024-01

2. Advancements in hydrogel-based drug delivery systems for the treatment of inflammatory bowel disease: a review;Biomaterials Science;2024

3. Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: latest advances;Journal of Materials Chemistry B;2024

4. 3D printed infliximab suppositories for rectal biologic delivery;International Journal of Pharmaceutics: X;2023-12

5. Recent advances on emerging nanomaterials for diagnosis and treatment of inflammatory bowel disease;Journal of Controlled Release;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3